BDNF-secreting T cells are reduced in untreated multiple sclerosis patients and increased after interferon beta treatment [40], while NGF, NT-3 and NT-4 production by PBMCs in multiple sclerosis patients is enhanced in the post-relapse phase [41]. Here, NTF3 is linked to multiple sclerosis.